$RMSL
RemSleep Holdings Inc. Stock $rmsl

$rmsl Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000121390024033498 Filed on April 16, 2024

Income Statement

Concept	2024 Q2	2023 Q4	2023
Revenue	$27.59K	$7.460K	$203.7K
YoY Change	-52.96%	-88.25%	-36.48%
Cost Of Revenue	$5.940K	$786.9K	$960.5K
YoY Change	-88.13%	986.55%	286.62%
Gross Profit	$21.65K	-$779.4K	-$756.7K
YoY Change	151.85%	8618.34%	-1146.77%
Gross Profit Margin	78.47%	-10447.99%	-371.46%
Selling, General & Admin	$186.5K	$73.31K	$720.1K
YoY Change	3.0%	-70.8%	-24.45%
% of Gross Profit	861.27%
Research & Development	$132.0K	$205.2K	$294.8K
YoY Change	169.81%	34.88%	-12.52%
% of Gross Profit	609.68%
Depreciation & Amortization	$26.09K	$38.36K	$102.2K
YoY Change	-3.12%	165.1%	67.32%
% of Gross Profit	120.49%
Operating Expenses	$318.5K	$278.5K	$1.015M
YoY Change	38.49%	-30.93%	-21.34%
Operating Profit	-$296.9K	-$1.058M	-$1.772M
YoY Change	34.09%	156.68%	45.47%
Interest Expense	$71.27K	$0.00	-$7.090K
YoY Change	3844.11%	-100.0%	-102.99%
% of Operating Profit
Other Income/Expense, Net	$71.27K		-$6.196K
YoY Change	-4043.88%		-97.69%
Pretax Income	-$225.6K	-$1.058M	-$1.778M
YoY Change	1.08%	153.21%	19.59%
Income Tax		$0.00	$0.00
% Of Pretax Income
Net Earnings	-$225.6K	-$1.058M	-$1.778M
YoY Change	1.08%	10.83%	19.59%
Net Earnings / Revenue	-817.57%	-14181.64%	-872.69%
Basic Earnings Per Share	$0.00		$0.00
Diluted Earnings Per Share	$0.00	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	1.462B shares	1.462B shares	1.462B shares
Diluted Shares Outstanding	1.472B shares		1.462B shares

Balance Sheet

Concept	2024 Q2	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$698.7K	$719.1K	$719.1K
YoY Change	-35.44%	-60.96%	-60.96%
Cash & Equivalents	$698.7K	$719.1K
Short-Term Investments
Other Short-Term Assets	$15.90K	$8.710K	$8.710K
YoY Change	6.0%
Inventory	$79.62K	$99.15K	$99.15K
Prepaid Expenses
Receivables	$10.29K	$9.030K	$9.030K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$804.5K	$836.0K	$836.0K
YoY Change	-61.39%	-71.27%	-71.27%
LONG-TERM ASSETS
Property, Plant & Equipment	$128.9K	$360.3K	$360.3K
YoY Change	-41.07%	161.15%	-18.33%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$10.00K	$10.00K	$10.00K
YoY Change	0.0%	0.0%	0.0%
Total Long-Term Assets	$261.9K	$370.3K	$370.3K
YoY Change	-44.19%	-17.92%	-17.93%
TOTAL ASSETS
Total Short-Term Assets	$804.5K	$836.0K	$836.0K
Total Long-Term Assets	$261.9K	$370.3K	$370.3K
Total Assets	$1.066M	$1.206M	$1.206M
YoY Change	-58.23%	-64.11%	-64.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$101.2K	$37.00K	$37.00K
YoY Change	621.68%	-32.54%	-32.54%
Accrued Expenses	$6.426K	$194.9K	$194.9K
YoY Change	-95.93%	-17.17%	-17.17%
Deferred Revenue	$36.00K
YoY Change
Short-Term Debt	$78.61K	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$493.9K	$231.9K	$231.9K
YoY Change	187.1%	-51.08%	-51.08%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities		$43.68K	$43.68K
YoY Change		-75.49%	-75.49%
Total Long-Term Liabilities		$43.68K	$43.68K
YoY Change		-75.49%	-75.49%
TOTAL LIABILITIES
Total Short-Term Liabilities	$493.9K	$231.9K	$231.9K
Total Long-Term Liabilities		$43.68K	$43.68K
Total Liabilities	$493.9K	$275.6K	$275.6K
YoY Change	67.91%	-57.75%	-57.75%
SHAREHOLDERS EQUITY
Retained Earnings	-$14.67M	-$14.19M
YoY Change	14.04%	14.32%
Common Stock	$1.482M	$1.462M
YoY Change	1.43%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$572.5K	$930.7K	$930.7K
YoY Change
Total Liabilities & Shareholders Equity	$1.066M	$1.206M	$1.206M
YoY Change	-58.23%	-64.11%	-64.11%

Cashflow Statement

Concept	2024 Q2	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$225.6K	-$1.058M	-$1.778M
YoY Change	1.08%	10.83%	19.59%
Depreciation, Depletion And Amortization	$26.09K	$38.36K	$102.2K
YoY Change	-3.12%	165.1%	67.32%
Cash From Operating Activities	-$151.9K	-$173.6K	-$791.3K
YoY Change	-49.93%	-36.03%	-64.58%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$11.67K	$147.6K
YoY Change		-77.03%	20.75%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00	-$11.67K	-$147.6K
YoY Change		-77.03%	20.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	120.0K	0.000	-183.9K
YoY Change	-251.53%	-100.0%	-122.58%
NET CHANGE
Cash From Operating Activities	-151.9K	-173.6K	-791.3K
Cash From Investing Activities	0.000	-11.67K	-147.6K
Cash From Financing Activities	120.0K	0.000	-183.9K
Net Change In Cash	-31.89K	-185.3K	-1.123M
YoY Change	-91.66%	-41.92%	-27.16%
FREE CASH FLOW
Cash From Operating Activities	-$151.9K	-$173.6K	-$791.3K
Capital Expenditures	$0.00	$11.67K	$147.6K
Free Cash Flow	-$151.9K	-$185.3K	-$939.0K
YoY Change	-49.93%	-42.5%	-60.15%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-53450
CY2023	dei	Entity Registrant Name EntityRegistrantName	REMSLEEP HOLDINGS, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-5386867
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	14175 ICOT Blvd
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 300
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Clearwater
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33760
CY2023	dei	City Area Code CityAreaCode	813
CY2023	dei	Local Phone Number LocalPhoneNumber	367-3855
CY2023	dei	Security12g Title Security12gTitle	Common Stock, $0.001 par value
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	16771918	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	1461616601	shares
CY2023	dei	Auditor Name AuditorName	Fruci & Associates II, PLLC
CY2023	dei	Auditor Location AuditorLocation	Spokane, Washington
CY2023Q4	us-gaap	Cash Cash	719100	usd
CY2022Q4	us-gaap	Cash Cash	1841988	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	5590	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9025	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	11698	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	8710	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	99147	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	1056007	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	835982	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	2909693	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	10000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	10000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	177796	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	303227	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	182536	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	137980	usd
CY2023Q4	us-gaap	Assets Assets	1206314	usd
CY2022Q4	us-gaap	Assets Assets	3360900	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	37000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	54845	usd
CY2023Q4	rmsl	Accrued Compensation AccruedCompensation	60500	usd
CY2022Q4	rmsl	Accrued Compensation AccruedCompensation	52000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	134438	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	93241	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	231938	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	474136	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	43676	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	178226	usd
CY2023Q4	us-gaap	Liabilities Liabilities	275614	usd
CY2022Q4	us-gaap	Liabilities Liabilities	652362	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1461616601	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1461616601	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1461616601	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1461616601	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	1461615	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1461615	usd
CY2023Q4	rmsl	Discount To Common Stock DiscountToCommonStock	94708	usd
CY2022Q4	rmsl	Discount To Common Stock DiscountToCommonStock	94708	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	13749052	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	13751052	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-14192759	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12414921	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	930700	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2708538	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1206314	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3360900	usd
CY2023	us-gaap	Revenues Revenues	203718	usd
CY2022	us-gaap	Revenues Revenues	320719	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	960457	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	248426	usd
CY2023	us-gaap	Gross Profit GrossProfit	-756739	usd
CY2022	us-gaap	Gross Profit GrossProfit	72293	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	116362	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	115135	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	294819	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	337033	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	136320	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	114702	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	295402	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	492295	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	1014903	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	1290165	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-1771642	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-1217872	usd
CY2023	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	7090	usd
CY2022	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	237390	usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	894	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-28264	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	3048	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-6196	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-268702	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1777838	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1486574	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1777838	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1486574	usd
CY2022	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	536732	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1777838	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2023306	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1461616601	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1461965506	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	2618622	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	721490	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	855000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1486574	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2708538	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1777838	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	930700	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1777838	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1486574	usd
CY2023	us-gaap	Depreciation Depreciation	102198	usd
CY2022	us-gaap	Depreciation Depreciation	61079	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	738113	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	3048	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	206157	usd
CY2023	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	-874	usd
CY2022	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	-28264	usd
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	32078	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	15732	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2673	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	11698	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	8710	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	47491	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-218747	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1056007	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-17845	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	39339	usd
CY2023	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	8500	usd
CY2022	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	5000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-13521	usd
CY2023	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-90119	usd
CY2022	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	22614	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-791329	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2234058	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	147628	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	122262	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-147628	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-122262	usd
CY2022	us-gaap	Repayments Of Debt RepaymentsOfDebt	45000	usd
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	183931	usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	4740	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	855000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-183931	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	814740	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1122888	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1541580	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1841988	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3383568	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	719100	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1841988	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	22140	usd
CY2022	us-gaap	Stock Issued1 StockIssued1	427730	usd
CY2022	rmsl	Establish Right Of Use Asset EstablishRightOfUseAsset	328803	usd
CY2023	rmsl	Series C Preferred Stock Issued For Intangibles Related Party SeriesCPreferredStockIssuedForIntangiblesRelatedParty	2000	usd
CY2023	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2007-06-06
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration:underline">Use of Estimates </span></i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</span></p>
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration:underline">Concentrations of Credit Risk</span></i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We maintain our cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. We continually monitor our banking relationships and consequently have not experienced any losses in our accounts. At times, such deposits may be in excess of the Federal Deposit Insurance Corporation insurable amount (“FDIC”). As of December 31, 2023 and 2022, the Company had $469,100 and $1,591,988 of cash above the FDIC’s $250,000 coverage limit, respectively.</span></p>
CY2023Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	469100	usd
CY2022Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	1591988	usd
CY2023	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	250000	usd
CY2023Q4	rmsl	Fixed Asset FixedAsset	2000	usd
CY2022	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	172500000	shares
CY2023	us-gaap	Revenue Recognition Allowances RevenueRecognitionAllowances	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration:underline">Revenue Recognition</span></i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes revenue under ASC 606, “Revenue from Contracts with Customers” (“ASC 606”). The Company determines revenue recognition through the following steps:</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification of a contract with a customer;</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification of the performance obligations in the contract;</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Determination of the transaction price;</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Allocation of the transaction price to the performance obligations in the contract; and</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recognition of revenue when or as the performance obligations are satisfied.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All orders are received online at which time payment is made. When payment is approved the product is shipped. When the product ships control of the promised goods is transferred to the customers and the revenue is recognized. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P2Y
CY2023	rmsl	Total Number Of Units Sold TotalNumberOfUnitsSold	1000	shares
CY2023Q4	us-gaap	Time Sharing Transactions Allowance For Uncollectible Accounts TimeSharingTransactionsAllowanceForUncollectibleAccounts	20886	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	5590	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	738113	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-14192759	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1777838	usd
CY2023	rmsl	Net Cash Used In Operating Activities NetCashUsedInOperatingActivities	791309	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	152854	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	61456	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	182536	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	137980	usd
CY2023	us-gaap	Depreciation Depreciation	102198	usd
CY2022	us-gaap	Depreciation Depreciation	61079	usd
CY2023Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	100000	usd
CY2023Q2	us-gaap	Repayments Of Debt RepaymentsOfDebt	79191	usd
CY2023Q2	us-gaap	Interest And Debt Expense InterestAndDebtExpense	97209	usd
CY2019Q1	rmsl	Balance Due Will Accrue Interest BalanceDueWillAccrueInterest	0.125	pure
CY2023	rmsl	Agreement Term AgreementTerm	P1Y
CY2023	us-gaap	Lessee Operating Lease Description LesseeOperatingLeaseDescription	The Company entered into a Lease Agreement (the “Lease”) with 14175 Icot Blvd, LLC (the “Lessor”), effective May 1, 2022, relating to approximately 9,677 square feet of property located at 14175 Icot Blvd, Clearwater, FL 33760.
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths	8686.71	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Two LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo	9034.17	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Three LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree	12287.63	usd
CY2023Q4	us-gaap	Prepaid Rent PrepaidRent	69494	usd
CY2023Q4	rmsl	Operating Lease Assets OperatingLeaseAssets	177796	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	177796	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	134438	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	43676	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	178114	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	134438	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	49151	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	183589	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	5475	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	178114	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	134438	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	43676	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	136320	usd
CY2023	us-gaap	Adjustment For Amortization AdjustmentForAmortization	103613	usd
CY2023Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	18928	usd
CY2023	us-gaap	Interest Expense InterestExpense	13779	usd
CY2023	us-gaap	Lease Cost LeaseCost	8675	usd
CY2022Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	114000000	shares
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	855000	usd
CY2023Q4	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	1	shares
CY2023Q3	rmsl	Percentage Of Common Stock Issued And Outstanding PercentageOfCommonStockIssuedAndOutstanding	0.81	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	373000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	312000	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	373000	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	312000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.21	pure
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2980000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2494000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2980000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2494000	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	2980000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	226500000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.0013
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y9M10D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	6000000	shares
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	60000000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	172500000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.0104
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y1M20D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1665500	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	172500000	shares
CY2024Q1	rmsl	Issuance Of Convertible Promissory Note Percentage IssuanceOfConvertiblePromissoryNotePercentage	0.10	pure
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023	dei	Auditor Firm AuditorFirmId	5525
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent		usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent		usd
CY2023	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments		usd
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1461616601	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1461965506	shares
CY2022	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1		usd
CY2022	us-gaap	Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount		usd
CY2023	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther		usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown		usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities		usd
CY2023	us-gaap	Repayments Of Debt RepaymentsOfDebt		usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023	us-gaap	Stock Issued1 StockIssued1		usd
CY2023	rmsl	Establish Right Of Use Asset EstablishRightOfUseAsset		usd
CY2022	rmsl	Series C Preferred Stock Issued For Intangibles Related Party SeriesCPreferredStockIssuedForIntangiblesRelatedParty		usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OperatingLeaseRightOfUseAsset
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OperatingLeaseRightOfUseAsset
CY2023Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OperatingLeaseLiabilityCurrent
CY2022Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OperatingLeaseLiabilityCurrent
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OperatingLeaseLiabilityNoncurrent
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OperatingLeaseLiabilityNoncurrent
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2022	rmsl	Sharebased Compensation Arrangement By Sharebased Payment Award Options Aggregate Intrinsic Value Granted SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAggregateIntrinsicValueGranted		usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2022	rmsl	Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value Expired ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueExpired		usd
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue		usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2023	rmsl	Sharebased Compensation Arrangement By Sharebased Payment Award Options Aggregate Intrinsic Value Granted SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAggregateIntrinsicValueGranted		usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2023	rmsl	Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value Expired ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueExpired		usd
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2023	rmsl	Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value Cancelled ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueCancelled		usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber		shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	No Trading Symbol Flag NoTradingSymbolFlag	true
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001412126

Files In Submission

Name	View Source	Status
0001213900-24-033498-index-headers.html	Edgar Link	pending
0001213900-24-033498-index.html	Edgar Link	pending
0001213900-24-033498.txt	Edgar Link	pending
0001213900-24-033498-xbrl.zip	Edgar Link	pending
ea0203609-10k_remsleep.htm	Edgar Link	pending
ea0203609-10k_remsleep_htm.xml	Edgar Link	completed
ea020360901ex31-1_rem.htm	Edgar Link	pending
ea020360901ex32-1_rem.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
rmsl-20231231.xsd	Edgar Link	pending
rmsl-20231231_cal.xml	Edgar Link	unprocessable
rmsl-20231231_def.xml	Edgar Link	unprocessable
Show.js	Edgar Link	pending
rmsl-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
rmsl-20231231_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RMSL
RemSleep Holdings Inc. Stock $rmsl

2024 Q2 Form 10-K Financial Statement

#000121390024033498 Filed on April 16, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RMSL RemSleep Holdings Inc. Stock $rmsl

2024 Q2 Form 10-K Financial Statement

#000121390024033498 Filed on April 16, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RMSL
RemSleep Holdings Inc. Stock $rmsl